Science
Mechanism of Action
This botanical ingredient exerts its effects through key active compounds: allantoin accelerates cell proliferation and collagen formation, promoting rapid wound healing and reducing scar visibility while enhancing hydration by supporting water retention. Rosmarinic acid provides robust anti-inflammatory and antioxidant defense, calming redness, mitigating irritation, and protecting against oxidative stress. Mucilage acts as a natural humectant, attracting and binding moisture to strengthen the skin barrier and alleviate dryness. Tannins impart astringent qualities, which can refine pore appearance, regulate sebum production, and offer a protective barrier against external aggressors.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 An 8% Symphytum officinale leaf extract, formulated in an oil/water emulsion, demonstrated significant wound healing capabilities in a rat model. This concentration notably increased collagen deposition by 40% to 240% and reduced cellular inflammatory infiltrate by 3% to 46% over 3 to 28 days, exhibiting optimal efficacy in inflammation control and collagen synthesis.
- 02 Comfrey extract, encompassing leaf extract, utilized at concentrations from 0.01 wt% to 1.0 wt% within a total composition, particularly with a comfrey-to-retinol ratio of 1:3 to 5:1, was shown to effectively diminish retinoid-induced skin irritation.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Ethanolic extracts of Symphytum officinale radix have been observed at a pH of 6.55, with anti-inflammatory assays conducted at pH 6.3, indicating stability in slightly acidic to neutral environments. Cellular extracts are water-soluble.
Synergies
- Retinol (to mitigate irritation)
Safety
Safety Profile
Symphytum officinale contains pyrrolizidine alkaloids (PAs), which pose a risk of liver damage if ingested and can be absorbed through the skin, particularly if the skin barrier is compromised or with prolonged/high-dose application. The FDA has advised against oral comfrey products. Topically, it is considered possibly safe for unbroken skin in small amounts for less than 6 weeks but potentially unsafe on broken skin or with extended use. It is explicitly deemed likely unsafe during pregnancy and breastfeeding due to potential teratogenicity. PA content in comfrey leaves typically ranges from 15 to 55 μg/g. German guidelines suggest a permissible daily PA dose of 100 μg, with treatment limited to 4-6 weeks for doses between 10-100 μg/day. Patch testing is recommended. Utilizing PA-free extracts is advised for cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its potent skin regenerative, anti-inflammatory, and hydrating benefits, the inherent presence of pyrrolizidine alkaloids (PAs) in Symphytum officinale leaf powder and the associated systemic absorption risks render its use generally unadvisable for topical applications, especially on compromised skin or during pregnancy, aligning with an 'avoid' recommendation for precision skincare.
Related
Similar Ingredients
Finding similar ingredients…